Rnf43 (RING finger protein 43) and Znrf3 (zinc/RING finger protein 3) (RZ) are two closely related transmembrane E3 ligases, encoded by Wnt target genes, that remove surface Wnt (wingless-int) receptors. The two genes are mutated in various human cancers. Such tumors are predicted to be hypersensitive to, yet still depend on, secreted Wnts. We previously showed that mutation of RZ in the intestine yields rapidly growing adenomas containing LGR5 + (leucine-rich repeatcontaining G-protein coupled receptor 5) stem cells and Wnt3-producing Paneth cells. We now show that removal of Paneth cells by Math1 mutation inhibits RZ −/− tumor formation. Similarly, deletion of Wnt3 inhibits tumorigenesis. Treatment of mice carrying RZ −/− intestinal neoplasia with a small molecule Wnt secretion inhibitor (porcupine inhibitor C59) strongly inhibited growth, whereas adjacent normal crypts remained intact. These results establish that paracrine Wnt secretion is an essential driver of RZ −/− tumor growth and imply that a therapeutic window exists for the use of porcupine inhibitors for RZ-mutant cancers.
Rnf43 (RING finger protein 43) and Znrf3 (zinc/RING finger protein 3) (RZ) are two closely related transmembrane E3 ligases, encoded by Wnt target genes, that remove surface Wnt (wingless-int) receptors. The two genes are mutated in various human cancers. Such tumors are predicted to be hypersensitive to, yet still depend on, secreted Wnts. We previously showed that mutation of RZ in the intestine yields rapidly growing adenomas containing LGR5
+ (leucine-rich repeatcontaining G-protein coupled receptor 5) stem cells and Wnt3-producing Paneth cells. We now show that removal of Paneth cells by Math1 mutation inhibits RZ −/− tumor formation. Similarly, deletion of Wnt3 inhibits tumorigenesis. Treatment of mice carrying RZ −/− intestinal neoplasia with a small molecule Wnt secretion inhibitor (porcupine inhibitor C59) strongly inhibited growth, whereas adjacent normal crypts remained intact. These results establish that paracrine Wnt secretion is an essential driver of RZ −/− tumor growth and imply that a therapeutic window exists for the use of porcupine inhibitors for RZ-mutant cancers.
RNF43 | ZNRF3 | LGR5 | Wnt | porcupine inhibitor R NF43 (RING finger protein 43) and ZNRF3 (zinc/RING finger protein 3) target Wnt (wingless-int) receptors (the Frizzleds) to the lysosomal degradation pathway by promoting their endocytosis (1, 2) . Encoded by stem cell-specific Wnt target genes, they constitute a crucial negative feedback loop in the Wnt signaling pathway (2). RNF43 is mutated in subsets of human cancers of the colon (2, 3), pancreas (4-6), stomach (7), ovary (8) , and liver (9), whereas ZNRF3 is mutated in adrenocortical carcinoma (10) and osteoblastoma (11) . Indeed, when both genes are mutated simultaneously in small intestinal stem cells in mice, tumors arise that consist almost entirely of LGR5 + (leucine-rich repeat-containing G-protein coupled receptor 5) stem cells and their Wnt3-producing niche cells, the Paneth cells (2) . The activity of these E3 ligases is negatively controlled by R-spondins (RSPO) and LGR4/5/6 (LGR) receptors that sequestrate RZ from Frizzled by forming a triple complex (1) . The molecular detail of the RSPO/RZ/LGR interaction has been resolved by multiple independent X-ray structures (12) (13) (14) . In our previous report, we have shown that epithelial organoids (15) derived from RZmutant tumors can grow in the absence of the Wnt-amplifier RSPO (2), indicative of their hypersensitivity to Wnt. However, RZ-null mutant organoids die in the presence of porcupine inhibitor IWP1, implying that they require paracrine Wnt (2), which, in organoids, is provided in the form of Wnt3 by Paneth cells (16) . Of note, additional Wnts are secreted by nonepithelial cells surrounding crypts, making Wnt3 nonessential in vivo (16) (17) (18) (19) . This result clearly indicated the Wnt dependency of tumorigenic RZ-null epithelial cells.
We asked whether Wnt3 produced by Paneth cells is essential for the unrestricted growth of RZ-mutant neoplasia in vivo. We first addressed These observations suggested that blocking the interaction between the tumorigenic intestinal stem and niche cell mediated by Wnt ligand can be an effective therapeutic intervention of tumors with mutations in Rnf43 and/or Znrf3. Small molecule porcupine inhibitors block palmitoylation of Wnt proteins, an essential step for secretion of Wnts (22) . It has been tested in the Wnt1-driven mouse mammary tumor model (MMTV-Wnt1; refs. 23 and 24).
Significance
Rnf43 (RING finger protein 43) and Znrf3 (zinc/RING finger protein 3), encoded by stem cell-specific Wnt (wingless-int) target genes, constitute a crucial negative feedback loop in the Wnt signaling pathway. Rnf43 is mutated in subsets of human cancers of the colon, pancreas, stomach, ovary, and liver, while Znrf3 is mutated in adrenocortical carcinoma and osteoblastoma. Indeed, when both genes are mutated simultaneously in small intestinal stem cells in mice, tumors arise within a few weeks. Treatment of mice carrying RZ −/− intestinal neoplasia with a small molecule Wnt secretion inhibitor strongly inhibited growth, while adjacent normal crypts remained intact. These results establish that paracrine Wnt secretion is an essential driver of RZ −/− tumor growth and imply that a therapeutic window exists for the use of porcupine inhibitors for RZ-mutant cancers. : Villin-Cre ERT2 conditional knockout mice with C59 porcupine inhibitor (50 mg/kg) directly after inducing RZ-null neoplasia by tamoxifen administration (Fig. 3A) . At this dosing, we noted no effects on functioning of normal crypts as shown by the presence of olfactomedin-4 (Olfm4 crucially depend on Wnt (16) (17) (18) (19) . However, the C59 porcupine inhibitor strongly suppressed the formation of RZ-null tumorigenic epithelium when provided from the neoplasia induction date onward (Fig. 3 F and G versus Fig. 3 D and E, respectively). Additional analysis for stem cell (Lgr5) and Paneth cell (Lysozyme) markers showed similar results (Fig. S1 ). Next, we tested whether C59 porcupine inhibitor affected established RZ-null intestinal neoplasia. RZ mutations were induced first by tamoxifen administration to Rnf43 f/f : Znrf3 f/f : Villin-Cre ERT2 conditional knockout mice. C59 porcupine inhibitor treatment was initiated 5 d after tamoxifen induction. At this time point, the mutant intestine is filled with Olfm4 + stem cells (Fig. 4B ) and Cryptdin1
+
Paneth cells (Fig. 4C) throughout the crypt epithelium. Again, C59 porcupine treatment for 5 d suppressed the outgrowth of RZ-mutant intestinal epithelium (Fig. 4 F and G versus Fig. 4 D and E, respectively). Additional stainings for stem cell (Lgr5) and Paneth cell (Lysozyme) markers showed similar results (Fig. S2) . Our data imply that cancer cells, carrying mutations in RNF43 and/or ZNRF3 as drivers of tumor growth, require a Wntsecreting niche. We demonstrate that blocking this Wnt niche function by porcupine inhibition attenuates aberrant RZ-null hyperplasia at doses that do not affect normal crypts. The existence of this therapeutic dose of porcupine inhibitor is particularly interesting with a high incidence of RNF43 mutations in various types of human cancer (2-9), including colorectal cancer (18%) (3). These observations indicate that the growing numbers of small molecule Wnt inhibitors may be tested in clinical trials of patients carrying malignant tumors with demonstrated mutations in RNF43 or ZNRF3.
Methods
Mice. The conditional Rnf43, Znrf3, Wnt3, and Math1 alleles and the transgenic Villin-Cre ERT2 line have been described (2, (25) (26) (27) (19) . The mice were killed on the indicated days and the intestines isolated. All procedures were performed in compliance with local animal welfare laws, guidelines, and policies.
Histology. The isolated mouse intestine was immediately fixed in formalin and embedded in paraffin by using standard procedures. The immunohistochemistry and in situ hybridization was carried out as described (2) . For immunohistochemistry, the primary antibodies were as follows: mouse anti-Ki67 (1:250, Monosan) and rabbit anti-Lysozyme (1:1,500; DAKO) and for in situ hybridization, the (DIG)-labeled RNA probes were as follows: Lgr5 (a kind gift of Fred de Sauvage, Genentech Inc., South San Francisco), Olfm4 (image clone 1078130), and Cryptdin1 (image clone 1096215).
Intestinal Organoid Culture. Crypt isolation, cell dissociation, and culture have been described (15) . For the analysis of organoid's growth under various conditions, established organoid cultures were dissociated into small pieces and seeded in matrigel (BD Biosciences) under the appropriate growth condition. Growth morphology of organoids was imaged, and viability of each organoid was scored.
